US Stock MarketDetailed Quotes

NAOV NanoVibronix

Watchlist
  • 0.5455
  • -0.0264-4.62%
Close Jan 8 16:00 ET
  • 0.5485
  • +0.0030+0.55%
Post 17:54 ET
2.05MMarket Cap-0.44P/E (TTM)

NanoVibronix Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-17.90%376K
177.89%817K
160.17%921K
203.59%2.28M
1,253.92%1.18M
372.16%458K
-39.38%294K
30.15%354K
-55.63%752K
-113.16%-102K
Operating revenue
-17.90%376K
177.89%817K
160.17%921K
203.59%2.28M
1,253.92%1.18M
372.16%458K
-39.38%294K
30.15%354K
-55.63%752K
-113.16%-102K
Cost of revenue
122.94%243K
398.72%389K
115.97%257K
27.52%746K
122.22%440K
541.18%109K
-61.76%78K
-28.31%119K
-36.76%585K
-61.78%198K
Gross profit
-61.89%133K
98.15%428K
182.55%664K
820.36%1.54M
345.67%737K
336.25%349K
-23.13%216K
121.70%235K
-78.31%167K
-216.73%-300K
Operating expense
8.24%1.1M
-10.04%1.1M
-4.50%1.23M
-3.98%4.97M
2.20%1.44M
1.49%1.02M
-20.92%1.23M
5.91%1.29M
-19.74%5.18M
-49.11%1.41M
Selling and administrative expenses
-13.39%854K
-23.11%915K
-10.04%1.11M
-2.21%4.79M
5.84%1.38M
3.25%986K
-20.03%1.19M
7.20%1.24M
-20.52%4.9M
-50.94%1.3M
-Selling and marketing expense
-4.74%181K
-12.33%199K
-22.90%165K
-10.47%864K
13.66%233K
-12.44%190K
-31.83%227K
1.90%214K
-12.35%965K
-17.67%205K
-General and administrative expense
-15.45%673K
-25.65%716K
-7.35%946K
-0.18%3.92M
4.38%1.14M
7.86%796K
-16.62%963K
8.39%1.02M
-22.30%3.93M
-54.39%1.1M
Research and development costs
654.55%249K
434.29%187K
120.00%121K
-34.63%185K
-42.06%62K
-32.65%33K
-42.62%35K
-16.67%55K
-3.41%283K
-6.96%107K
Operating profit
-44.78%-970K
33.20%-674K
46.16%-568K
31.44%-3.44M
58.90%-702K
27.49%-670K
20.43%-1.01M
5.13%-1.06M
11.81%-5.01M
31.95%-1.71M
Net non-operating interest income expense
53.70%-25K
80.39%-10K
67.50%-13K
38.65%-246K
71.75%-100K
-237.50%-54K
-183.33%-51K
-207.69%-40K
-735.42%-401K
-1,763.16%-354K
Non-operating interest expense
-5.71%33K
3.03%34K
0.00%34K
-61.10%135K
-90.49%33K
--35K
--33K
--34K
--347K
1,296.55%347K
Total other finance cost
-142.11%-8K
-233.33%-24K
-450.00%-21K
105.56%111K
857.14%67K
18.75%19K
0.00%18K
-53.85%6K
12.50%54K
--7K
Other net income (expense)
Income before tax
-37.43%-995K
35.53%-684K
46.94%-581K
31.98%-3.68M
61.11%-802K
22.98%-724K
17.50%-1.06M
2.67%-1.1M
62.01%-5.41M
18.47%-2.06M
Income tax
0.00%3K
-69.23%4K
250.00%7K
-17.14%29K
466.67%11K
-80.00%3K
-18.75%13K
-71.43%2K
9.38%35K
94.55%-3K
Net income
-37.28%-998K
35.94%-688K
46.40%-588K
31.88%-3.71M
60.51%-813K
23.87%-727K
17.51%-1.07M
3.09%-1.1M
61.85%-5.45M
16.77%-2.06M
Net income continuous Operations
-37.28%-998K
35.94%-688K
46.40%-588K
31.88%-3.71M
60.51%-813K
23.87%-727K
17.51%-1.07M
3.09%-1.1M
61.85%-5.45M
16.77%-2.06M
Minority interest income
Net income attributable to the parent company
-37.28%-998K
35.94%-688K
46.40%-588K
31.88%-3.71M
60.51%-813K
23.87%-727K
17.51%-1.07M
3.09%-1.1M
61.85%-5.45M
16.77%-2.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-37.28%-998K
35.94%-688K
46.40%-588K
31.88%-3.71M
60.51%-813K
23.87%-727K
17.51%-1.07M
3.09%-1.1M
61.85%-5.45M
16.77%-2.06M
Basic earnings per share
14.29%-0.36
61.54%-0.25
65.67%-0.23
44.79%-2.12
72.54%-0.39
38.24%-0.42
30.11%-0.65
17.28%-0.67
66.17%-3.84
27.18%-1.42
Diluted earnings per share
14.29%-0.36
61.54%-0.25
65.67%-0.23
44.79%-2.12
72.54%-0.39
38.24%-0.42
30.11%-0.65
17.28%-0.67
66.17%-3.84
27.18%-1.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -17.90%376K177.89%817K160.17%921K203.59%2.28M1,253.92%1.18M372.16%458K-39.38%294K30.15%354K-55.63%752K-113.16%-102K
Operating revenue -17.90%376K177.89%817K160.17%921K203.59%2.28M1,253.92%1.18M372.16%458K-39.38%294K30.15%354K-55.63%752K-113.16%-102K
Cost of revenue 122.94%243K398.72%389K115.97%257K27.52%746K122.22%440K541.18%109K-61.76%78K-28.31%119K-36.76%585K-61.78%198K
Gross profit -61.89%133K98.15%428K182.55%664K820.36%1.54M345.67%737K336.25%349K-23.13%216K121.70%235K-78.31%167K-216.73%-300K
Operating expense 8.24%1.1M-10.04%1.1M-4.50%1.23M-3.98%4.97M2.20%1.44M1.49%1.02M-20.92%1.23M5.91%1.29M-19.74%5.18M-49.11%1.41M
Selling and administrative expenses -13.39%854K-23.11%915K-10.04%1.11M-2.21%4.79M5.84%1.38M3.25%986K-20.03%1.19M7.20%1.24M-20.52%4.9M-50.94%1.3M
-Selling and marketing expense -4.74%181K-12.33%199K-22.90%165K-10.47%864K13.66%233K-12.44%190K-31.83%227K1.90%214K-12.35%965K-17.67%205K
-General and administrative expense -15.45%673K-25.65%716K-7.35%946K-0.18%3.92M4.38%1.14M7.86%796K-16.62%963K8.39%1.02M-22.30%3.93M-54.39%1.1M
Research and development costs 654.55%249K434.29%187K120.00%121K-34.63%185K-42.06%62K-32.65%33K-42.62%35K-16.67%55K-3.41%283K-6.96%107K
Operating profit -44.78%-970K33.20%-674K46.16%-568K31.44%-3.44M58.90%-702K27.49%-670K20.43%-1.01M5.13%-1.06M11.81%-5.01M31.95%-1.71M
Net non-operating interest income expense 53.70%-25K80.39%-10K67.50%-13K38.65%-246K71.75%-100K-237.50%-54K-183.33%-51K-207.69%-40K-735.42%-401K-1,763.16%-354K
Non-operating interest expense -5.71%33K3.03%34K0.00%34K-61.10%135K-90.49%33K--35K--33K--34K--347K1,296.55%347K
Total other finance cost -142.11%-8K-233.33%-24K-450.00%-21K105.56%111K857.14%67K18.75%19K0.00%18K-53.85%6K12.50%54K--7K
Other net income (expense)
Income before tax -37.43%-995K35.53%-684K46.94%-581K31.98%-3.68M61.11%-802K22.98%-724K17.50%-1.06M2.67%-1.1M62.01%-5.41M18.47%-2.06M
Income tax 0.00%3K-69.23%4K250.00%7K-17.14%29K466.67%11K-80.00%3K-18.75%13K-71.43%2K9.38%35K94.55%-3K
Net income -37.28%-998K35.94%-688K46.40%-588K31.88%-3.71M60.51%-813K23.87%-727K17.51%-1.07M3.09%-1.1M61.85%-5.45M16.77%-2.06M
Net income continuous Operations -37.28%-998K35.94%-688K46.40%-588K31.88%-3.71M60.51%-813K23.87%-727K17.51%-1.07M3.09%-1.1M61.85%-5.45M16.77%-2.06M
Minority interest income
Net income attributable to the parent company -37.28%-998K35.94%-688K46.40%-588K31.88%-3.71M60.51%-813K23.87%-727K17.51%-1.07M3.09%-1.1M61.85%-5.45M16.77%-2.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -37.28%-998K35.94%-688K46.40%-588K31.88%-3.71M60.51%-813K23.87%-727K17.51%-1.07M3.09%-1.1M61.85%-5.45M16.77%-2.06M
Basic earnings per share 14.29%-0.3661.54%-0.2565.67%-0.2344.79%-2.1272.54%-0.3938.24%-0.4230.11%-0.6517.28%-0.6766.17%-3.8427.18%-1.42
Diluted earnings per share 14.29%-0.3661.54%-0.2565.67%-0.2344.79%-2.1272.54%-0.3938.24%-0.4230.11%-0.6517.28%-0.6766.17%-3.8427.18%-1.42
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Collegium Pharmaceutical
COLL
+14.41%
eBay
EBAY
+9.86%
Halozyme Therapeutics
HALO
+5.02%
SilverCrest Metals
SILV
+4.63%
Workday
WDAY
+2.01%

Unlock the Full List